Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr
Unisys (NYSE: UIS) announces the date for its first-quarter 2024 financial results and conference call and its participation in upcoming investor conferences.
PLANO, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. (Nasdaq: KPLT) (“Katapult” or the “Company”), today announced the filing of its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). As disclosed in the Form 10-K, the filing cures a listing deficiency set forth in a notice the Company received from Nasdaq on April 18, 2024. The notice stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not timely fi
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|